bloomberg.com / Page 7

Intellia Therapeutics Inc. shares dropped after the company said a patient died after suffering liver damage in a clinical trial for the company's gene-editing treatment.

Property tycoon Michael Fuchs is in a "perilous" financial state with debts of more than $250 million, his lawyers claimed after his ex-wife demanded he be jailed for breaching a court ruling on their bitter divorce.

Danish drugmaker Novo Nordisk A/S was at the forefront of the weight-loss injection boom as people discovered that its Ozempic shot, originally developed to treat diabetes, could help trim their waistlines.

Brazilian rare earths producer Serra Verde secured as much as $465 million in funding from the US International Development Finance Corporation as Western nations seek to reduce reliance on China for the key minerals.

US stocks extended declines on Friday, putting benchmarks on track to snap a string of weekly gains as investors continued to fret about stretched valuations in the tech sector.

China has unveiled plans to sell up to 4 billion ($4.6 billion) of euro-denominated government bonds later this month, with the ink barely dry on a $4 billion debt sale earlier this week.

Investors in Jamaica's catastrophe bond now face a 100% payout after Hurricane Melissa set off a full trigger event, according to the World Bank.

Target Corp. is leaning into "Minnesota Nice."

South African's appetite for buying clothes, food and fridges online is likely to defy weak consumer spending as e-commerce grows by as much 50% in the next year, according to the head of local apparel retailer The Foschini Group Ltd.

Traders are pondering a moment of weakness embedded in a multi-month rip higher for stocks, yet the market on balance looks poised for further gains, said Goldman Sachs Group Inc.'s Tony Pasquariello.